TYBR Health Analysis
What is TYBR Health?
TYBR Health develops biomaterials to protect tendons and ligaments during recovery, enhancing healing and minimizing complications from scarring after surgery.
Employees
3
Founded
2020
Revenue
$0-5M
Company Stage
Seed
YC Batch
W22
Product Features & Capabilities
- Healing tendon and ligament protection, Hydrogel for scar prevention, Internal organ scar prevention, Extracellular matrix solution for adhesion prevention.
Who are the founders of TYBR Health
TK
Tim Keane
CEO
AS
Alex Smith
CTO
Market Focus
TYBR Health primarily focuses on the healthcare industry, specifically in the development of innovative biomaterial therapies for the protection and healing of tendons and ligaments during recovery after surgery.
Investors
- Asymmetry Ventures
- Johnson & Johnson Innovation - JJDC
- Texas Medical Center
- VentureSouq
- MedTech Innovator
- Eight Capital
- Creative Destruction Lab
- Y Combinator
- JLabs
- Ariel Southeast Angel Partners
Competitors Overview
TYBR Health operates in the biomaterial therapies market, specifically focusing on products that protect tendons and ligaments during the healing process. Its main competitors include:
- Artelon: This company specializes in improving ligament and tendon repair surgery with proprietary biomater
See something that needs updating? Suggest edits to this profile.